| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 03/27/2002 | EP0773946B1 Imidazopyridine-azolidinones |
| 03/27/2002 | EP0766670B1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 03/27/2002 | CN1342153A Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in production of medicaments |
| 03/27/2002 | CN1342147A NItroxyderivatives having antiinflammatory, analgesic and antithrombotic activity |
| 03/27/2002 | CN1342140A 硫代酰胺衍生物 Thioamide derivatives |
| 03/27/2002 | CN1342137A N2 phenylamidine derivatives |
| 03/27/2002 | CN1341593A Proteinase inhibitor |
| 03/27/2002 | CN1341592A Proteinase inhibitor |
| 03/27/2002 | CN1341590A Proteinase inhibitor |
| 03/27/2002 | CN1081625C 1-aryl-2-acylamino-ethane compounds and their use as meurokinin especially neurokinin 1 antagonists |
| 03/27/2002 | CN1081622C Carboxylic acid derivative preparation process |
| 03/26/2002 | US6362379 Acrylates having high degree of halogenation and polymers using these monomers; useful for optical waveguides and telecommunication |
| 03/26/2002 | US6362371 β2- adrenergic receptor agonists |
| 03/26/2002 | US6362369 Phthalic acid diamide derivatives fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides |
| 03/26/2002 | US6362231 Calcium receptor active compounds |
| 03/26/2002 | US6362230 Alzheimer's disease |
| 03/26/2002 | US6362228 Phenethyl-thiourea compounds and use |
| 03/26/2002 | US6362210 Carboxylic acid amides, pharmaceutical compositions containing these compounds and their use |
| 03/26/2002 | US6362204 Controlling immunology; antiinflammatory agents |
| 03/26/2002 | US6362195 Inhibitor of nitric oxide synthase; central nervous system disorders |
| 03/26/2002 | US6362193 Antiinflammatory agents |
| 03/26/2002 | US6362183 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 03/26/2002 | US6362177 Cyclic amine derivatives and their use as drugs |
| 03/26/2002 | US6361920 Photographic material containing a novel hydrazide type |
| 03/26/2002 | US6361571 Using tautomeric nonoxidative dyes and polymethine dyes |
| 03/26/2002 | CA2094703C Substituted piperazines as central nervous system agents |
| 03/21/2002 | WO2002022628A1 Cr complexes and their use for the polymerization of alpha-olefins |
| 03/21/2002 | WO2002022600A2 Chemokine receptor binding heterocyclic compounds |
| 03/21/2002 | WO2002022599A2 Chemokine receptor binding heterocyclic compounds |
| 03/21/2002 | WO2002022592A2 Substituted urea neuropeptide y y5 receptor antagonists |
| 03/21/2002 | WO2002022588A1 Novel pyrimidine derivative and novel pyridine derivative |
| 03/21/2002 | WO2002022584A1 Thrombin inhibitors |
| 03/21/2002 | WO2002022583A2 Pyridinyl amides and imides for use as fungicides |
| 03/21/2002 | WO2002022581A1 Nitrogen-containing compounds and their use as glycine transport inhibitors |
| 03/21/2002 | WO2002022556A1 Novel amide derivatives and medicinal use thereof ugs |
| 03/21/2002 | WO2001070694A8 Amorphous torasemide modification |
| 03/21/2002 | WO2001068664A3 Mass labels |
| 03/21/2002 | WO2001068568A3 Il-8 receptor antagonists |
| 03/21/2002 | WO2001064826A3 Composition and method for bleaching a substrate |
| 03/21/2002 | WO2001055106A3 Novel melanocortin receptor agonists and antagonists |
| 03/21/2002 | US20020035264 Therapy for vision disorders |
| 03/21/2002 | US20020035261 Synthesis of intermediates useful in preparing tricyclic compounds |
| 03/21/2002 | US20020035136 Amino(oxo) acetic acid protein tyrosine phosphatase inhibitors |
| 03/21/2002 | US20020035127 Phenylalanine derivatives |
| 03/21/2002 | US20020035123 For treating pain or memory deficiencies related to Alzheimer's disease and other neurodegenerative disorders associated with aging |
| 03/21/2002 | US20020035109 Benzamidine derivatives and their use as anti-coagulants |
| 03/21/2002 | US20020035094 Substituted pyridine compounds and methods of use |
| 03/21/2002 | CA2422044A1 Nitrogen-containing compounds and their use as glycine transport inhibitors |
| 03/21/2002 | CA2422013A1 Substituted urea neuropeptide y y5 receptor antagonists |
| 03/21/2002 | CA2419224A1 Chemokine receptor binding heterocyclic compounds |
| 03/21/2002 | CA2419219A1 Chemokine receptor binding heterocyclic compounds |
| 03/21/2002 | CA2357469A1 Process for producing non-proteinogenic l-amino acids by fermentation |
| 03/20/2002 | EP1188762A1 Chromium complexes and their use for the polymerization of alpha-olefins |
| 03/20/2002 | EP1188750A1 Process for the preparation of 2,5-diamino-4,6-dihalogenopyrimidinen |
| 03/20/2002 | EP1188745A1 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same |
| 03/20/2002 | EP1187856A1 Transition metal complexes and olefin polymerization process |
| 03/20/2002 | EP1187833A1 Method of producing nitroguanidine- and nitroenamine derivatives |
| 03/20/2002 | EP1187817A1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
| 03/20/2002 | EP1187815A1 4-phenyl-pyrimidine derivatives |
| 03/20/2002 | EP1187814A2 5-phenyl-pyrimidine derivatives |
| 03/20/2002 | EP1187812A2 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors |
| 03/20/2002 | EP1187605A1 Non-malignant disease treatment with ras antagonists |
| 03/20/2002 | EP1187592A2 Alpha v integrin receptor antagonists |
| 03/20/2002 | EP1060015A4 Sonic method of enhancing chemical reactions |
| 03/20/2002 | EP1019050B1 Use of somatostatin agonists and antagonists for treating diseases related to the eye |
| 03/20/2002 | EP0944590B1 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 03/20/2002 | EP0944587B1 Metalloproteinase inhibitors |
| 03/20/2002 | EP0929508B1 Liquid crystalline (e,e)-butadiene compounds and mixtures and devices containing such compounds |
| 03/20/2002 | CN1341103A Pyridazin-3-one derivatives and medicines containing the same |
| 03/20/2002 | CN1341101A Phenyl-and pyridinyl derivatives |
| 03/20/2002 | CN1341100A 3-phenylpyridine derivatives and their use as nk-1 receptor antagonists |
| 03/20/2002 | CN1341099A 2-aminopyridines containing fused ring substituents |
| 03/20/2002 | CN1341098A W-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 03/20/2002 | CN1341095A Amide compounds for potentiation of cholinergic activity |
| 03/20/2002 | CN1340500A Position 3 or 4 substituted phenyl compound, its preparing process and its application |
| 03/19/2002 | US6359134 Sulfonamide derivatives, their production and use |
| 03/19/2002 | US6359061 Combinatorial libraries are useful for screening in biologcal assays in order to identify pharmaceutically useful compounds |
| 03/19/2002 | US6358981 Sulphonamide derivatives |
| 03/19/2002 | US6358960 For therapy of intravascular coagulation, coronary thrombosis, cerebral infarction, cerebral embolism, transient ischemic attack, cerebrovascular disorders, pulmonary vascular diseases, deep venous thrombosis, etc. |
| 03/19/2002 | US6358958 Arylpiperazines having activity at the serotonin 1A receptor |
| 03/19/2002 | US6358945 Compounds useful as anti-inflammatory agents |
| 03/19/2002 | US6358883 Pesticidal and parasiticidal use of 1-aryl-1-(substituted thio, sulfinyl and sulfonyl)-2-nitroethane compounds |
| 03/19/2002 | US6358515 Hydroquinone derivatives |
| 03/19/2002 | US6358504 Compounds and compositions for delivering active agents |
| 03/19/2002 | US6358286 Less selective colorations and which are particularly resistant to the various attacking factors to which the hair may be subjected |
| 03/14/2002 | WO2002020523A1 Process for preparing a substituted imidazopyridine compound |
| 03/14/2002 | WO2002020501A2 Polyarylcarboxamides useful as lipid lowering agents |
| 03/14/2002 | WO2002020500A2 Materials and methods to potentiate cancer treatment |
| 03/14/2002 | WO2002020495A2 Inhibitors of glycogen synthase kinase 3 |
| 03/14/2002 | WO2002020487A1 Substituted 1-aryl-pyridin-2-(thi)ones |
| 03/14/2002 | WO2002020486A2 Picolinic acid derivatives for the prevention and treatment of cancer in animals |
| 03/14/2002 | WO2002020465A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3 |
| 03/14/2002 | WO2002020437A2 Basic compounds containing tertiary amides with activity on tachykinin receptors, and pharmaceutical compositions containing them |
| 03/14/2002 | WO2001070757A3 Thioketals and thioethers for inhibiting the expression of vcam-1 |
| 03/14/2002 | WO2001070692A3 Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides |
| 03/14/2002 | WO2001070673A3 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a) |
| 03/14/2002 | WO2001070668B1 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 03/14/2002 | WO2001068612A3 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 03/14/2002 | WO2001058852A3 (r)-2-aryl-propionamides, useful in the inhibition of il-8-induced chemiotaxis of neutrophils |
| 03/14/2002 | US20020032339 Aryl borates |